Seres Therapeutics, Inc. - COMMON STOCK (MCRB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
MCRB on Nasdaq
Shares outstanding
8,667,871
Price per share
$15.14
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,441,565
Total reported value
$36,368,373
% of total 13F portfolios
0%
Share change
+313,685
Value change
+$4,536,402
Number of holders
35
Price from insider filings
$15.14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 3.1% -43% $3,377,609 -$2,827,043 268,704 -46% FMR LLC 30 Jun 2025

As of 31 Dec 2025, 35 institutional investors reported holding 2,441,565 shares of Seres Therapeutics, Inc. - COMMON STOCK (MCRB). This represents 28% of the company’s total 8,667,871 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) together control 28% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Flagship Pioneering, LLC 13% 1,155,850 0% 5.3% $17,236,411
VANGUARD GROUP INC 3.7% 324,214 +4% 0% $4,824,304
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2.1% 179,929 0% $2,677,344
MARSHALL WACE, LLP 1.4% 120,177 -4.3% 0% $1,788,234
BlackRock, Inc. 1.2% 103,621 +1.5% 0% $1,541,880
Vontobel Holding Ltd. 1.2% 103,234 +4.8% 0.01% $1,536,122
GEODE CAPITAL MANAGEMENT, LLC 0.99% 86,142 +1.4% 0% $1,282,308
683 Capital Management, LLC 0.6% 52,314 0.06% $778,432
STATE STREET CORP 0.39% 33,901 +14% 0% $504,447
Lion Point Capital, LP 0.36% 31,570 +16% 2.4% $469,762
CITADEL ADVISORS LLC 0.36% 31,418 +1.7% 0% $467,500
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.36% 31,369 -0.11% 0% $466,771
Schonfeld Strategic Advisors LLC 0.34% 29,097 +0.54% 0% $432,961
TWO SIGMA INVESTMENTS, LP 0.3% 25,749 0% $383,145
MORGAN STANLEY 0.29% 25,126 +37% 0% $373,874
AMERICAN CENTURY COMPANIES INC 0.19% 16,271 0% $242,112
NORTHERN TRUST CORP 0.17% 14,765 +22% 0% $219,704
OMERS ADMINISTRATION Corp 0.17% 14,400 0% $214,272
Invesco Ltd. 0.17% 14,360 +38% 0% $213,677
GOLDMAN SACHS GROUP INC 0.17% 14,340 0% $213,379
ExodusPoint Capital Management, LP 0.15% 12,737 0% $189,527
BARCLAYS PLC 0.09% 7,432 +428% 0% $110,588
UBS Group AG 0.05% 4,226 -67% 0% $62,883
SBI Securities Co., Ltd. 0.04% 3,482 0% 0% $51,812
FMR LLC 0.02% 1,740 -7.5% 0% $25,891

Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,441,565 $36,368,373 +$4,536,402 $14.88 35
2025 Q3 2,125,842 $40,902,370 -$2,393,659 $19.24 32
2025 Q2 2,284,946 $25,385,817 +$24,555,434 $11.11 33
2025 Q1 145,407 $101,799 +$101,799 $0.70 4